Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07148193

Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)

Sponsor: Technische Universität Dresden

View on ClinicalTrials.gov

Summary

The study PROSa+ aims to assess patient-reported outcomes (PROs), patient-reported experiences (PREs), and the socioeconomic situation of long-term sarcoma survivors (≥ 5 years post-diagnosis, with or without active disease) in Germany. The mixed-methods research design includes a multicenter observational study with a cross-sectional questionnaire survey involving 1,600 participants (paper, online), qualitative interviews with up to 60 participants, and longitudinal analyses combining data from existing sarcoma registries and the previous PROSa study conducted between 2017 and 2020.

Official title: Understanding Long-Term Sarcoma Survivorship: Risk Profiles, Outcomes and Unmet Needs - A Joint Project of Research, Sarcoma Centres and Patient Experts (PROSa+)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1600

Start Date

2025-11-28

Completion Date

2027-09

Last Updated

2025-12-08

Healthy Volunteers

No

Interventions

OTHER

No intervention (observational study)

No intervention (observational study)

Locations (5)

Technical University Dresden

Dresden, Saxony, Germany

University Hospital Essen

Essen, Germany

NCT Heidelberg

Heidelberg, Germany

Sarcoma Center Mannheim

Mannheim, Germany

Deutsche Sarkom-Stiftung

Wölfersheim, Germany